Combined Use of Prostate-specific Antigen Density and Magnetic Resonance Imaging for Prostate Biopsy Decision Planning: A Retrospective Multi-institutional Study Using the Prostate Magnetic Resonance Imaging Outcome Database (PROMOD)Ugo Giovanni Falagario, Giuseppe Carrieri, Nicola Fossati et al.|European Urology Oncology|2020Cited by 105
Predicting the Need for Biopsy to Detect Clinically Significant Prostate Cancer in Patients with a Magnetic Resonance Imaging–detected Prostate Imaging Reporting and Data System/Likert ≥3 Lesion: Development and Multinational External Validation of the Imperial Rapid Access to Prostate Imaging and Diagnosis Risk ScoreMax Peters, Hashim U. Ahmed, David Eldred‐Evans et al.|European Urology|2022Cited by 38
The Mount Sinai Prebiopsy Risk Calculator for Predicting any Prostate Cancer and Clinically Significant Prostate Cancer: Development of a Risk Predictive Tool and Validation with Advanced Neural Networking, Prostate Magnetic Resonance Imaging Outcome Database, and European Randomized Study of Screening for Prostate Cancer Risk CalculatorSneha Parekh, Ash Tewari, Parita Ratnani et al.|European Urology Open Science|2022Cited by 26
Detection of Prostate Cancer Using Biparametric Prostate <scp>MRI</scp>, Radiomics, and Kallikreins: A Retrospective Multicenter Study of Men With a Clinical Suspicion of Prostate CancerIleana Montoya Perez, Hannu J. Aronen, Harri Merisaari et al.|Journal of Magnetic Resonance Imaging|2021Cited by 13
How to read biparametric MRI in men with a clinical suspicious of prostate cancer: Pictorial review for beginners with public access to imaging, clinical and histopathological databaseIvan Jambor, Hannu J. Aronen, Alberto Martini et al.|Acta Radiologica Open|2021Cited by 2